The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTanfield Regulatory News (TAN)

Share Price Information for Tanfield (TAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.76
Bid: 3.60
Ask: 3.92
Change: 0.00 (0.00%)
Spread: 0.32 (8.889%)
Open: 3.76
High: 0.00
Low: 0.00
Prev. Close: 3.76
TAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Snorkel Investment & Loan Subscription Update

24 Aug 2022 07:00

RNS Number : 9914W
Tanfield Group PLC
24 August 2022
 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain

 

 

Tanfield Group Plc

("Tanfield" or the "Company")

 

Snorkel Investment & Loan Subscription Update

 

 

The Board of Tanfield (the "Board") is pleased to update the market on its investment in Snorkel International Holdings LLC ("Snorkel"), the aerial work platform business, as well as with respect to additional loan subscriptions.

 

 

Investment Background

 

· Tanfield is a 49% shareholder in the equity of Snorkel following the joint venture between the Company and Xtreme Manufacturing LLC ("Xtreme") (the "Contemplated Transaction"), a company owned by Don Ahern of Ahern Rentals Inc, relating to Snorkel, in October 2013.

 

· The Snorkel investment is valued at £19.1m. The outcome of the US and UK Proceedings referenced below could have an impact on this valuation.

 

· On 22 October 2019, the Company announced that it had received a Summons and Complaint, filed in Nevada (the "US Proceedings") by subsidiaries of Xtreme, relating to the Contemplated Transaction.

 

· On 24 October 2019, the Company announced it had become necessary to issue and serve a claim in the English High Court against Ward Hadaway (the "UK Proceedings"), the solicitor acting for the Company at the time of the Contemplated Transaction, in order to fully protect the Company's rights pending the outcome of the US Proceedings. 

 

· On 26 February 2021, Ward Hadaway was granted permission to join Foulston Siefkin, Tanfield's US based law firm who were retained in 2013 to draft the documents governed by US law relating to the Contemplated Transaction, into the UK Proceedings. As a result, the Company amended its claim to include Foulston Siefkin as a second defendant.

 

 

Highlights

 

· In the second quarter of 2022, Snorkel achieved further sales growth as it continued to recover following the global COVID-19 pandemic. Sales for the quarter increased to US$46.8m, compared to US$40.3m for the second quarter of 2021, an increase of 16.3%. This resulted in sales for the first 6 months of 2022 being US$88.6m, compared to US$71.7m for the same period in 2021, an increase of 23.5%.

 

· Despite the increase in sales, the EBITDA for the second quarter of 2022 was a loss of US$4.3m, compared to a profit of US$0.2m for the second quarter of 2021. Likewise, the EBITDA loss for the first six months of 2022 increased to US$7.8m, compared to US$2.5m for the same period in 2021. 

 

 

Business Update

 

Tanfield is a 49% shareholder in the equity of Snorkel following the joint venture between the Company and Xtreme, a company owned by Don Ahern of Ahern Rentals Inc, relating to Snorkel, in October 2013.

 

Snorkel continues to recover from the impact of the global COVID-19 pandemic, which impacted its ability to operate as normal, and has seen sales for the second quarter of 2022 increase to US$46.8m, compared to US$40.3m for the second quarter of 2021, an increase of 16.3%. This resulted in sales for the first 6 months of 2022 being US$88.6m, compared to US$71.7m for the same period in 2021, an increase of 23.5%. 

 

Despite the increase in sales, the EBITDA for the second quarter of 2022 was a loss of US$4.3m, compared to a profit of US$0.2m for the same period in 2021. Likewise, the EBITDA loss for the first six months of 2022 increased to US$7.8m, compared to US$2.5m for the same period in 2021. The Board once again note that the gross profit margin has reduced even further to 2.8% for the second quarter of 2022, compared to 8.9% for the second quarter of 2021 and the already low level of 4.1% in Q1 2022. The Board is unaware of the reason for the continuing reduction to the gross profit margin and continues to believe that it is not in line with the industry averages. Work to investigate this is ongoing.

 

To highlight the dramatic change in recent years, at the height of the pandemic in Q2 2020, Snorkel achieved sales of only US$16.8m and reported an EBITDA loss of US$4.3m. 2 years later in Q2 2022, Snorkel sales have increased by almost 179% to US$46.8m compared to Q2 2020, yet the reported EBITDA in both periods is a loss of around US$4.3m. To put this further into context, in Q2 2017 Snorkel achieved a slightly lower level of sales at US$44.9m and yet in that quarter reported an EBITDA profit of US$1.0m, some US$5.3m higher than the loss reported in Q2 2022.

 

 

Below is a summary of the consolidated financial statement for the second quarter of 2022, including comparative figures for the previous 5 years:

 

US$000's

Q2 2022

Q2 2021

Q2 2020

Q2 2019

Q2 2018

Q2 2017

 

Net sales

46,848

40,286

16,818

60,848

51,766

44,870

Cost of goods sold

45,521

36,720

16,852

52,951

45,108

39,084

Gross profit

1,327

3,566

(34)

7,897

6,658

5,786

Gross profit margin

2.8%

8.9%

(0.2%)

13.0%

12.9%

12.9%

Selling, general, admin &

currency costs

5,592

3,414

4,218

5,926

5,211

4,761

EBITDA

(4,265)

152

(4,252)

1,971

1,447

1,025

 

 

Below is a summary of the consolidated financial statement for the first six months of 2022, including comparative figures for the previous 5 years:

 

US$000's

H1 2022

H1 2021

H1 2020

H1 2019

H1 2018

H1 2017

 

Net sales

88,554

71,717

60,242

112,452

96,302

79,749

Cost of goods sold

85,514

66,126

56,598

98,682

84,033

69,181

Gross profit

3,040

5,591

3,643

13,770

12,269

10,569

Gross profit margin

3.4%

7.8%

6.0%

12.2%

12.7%

13.3%

Selling, general, admin &

currency costs

10,784

8,069

9,546

12,754

11,480

9,164

EBITDA

(7,744)

(2,478)

(6,212)

1,016

789

1,404

 

 

The Board is not able to determine if or when Snorkel's sales might return to pre-pandemic levels. However, it views the ongoing increase to sales as a positive development and is not aware of any reason why this improving trend should not continue. 

 

Loan Subscription

 

Further to the update on 24 May 2022, in which the Company announced that the first loan note instrument (the "First Loan") of up to £700,000 had subscriptions totalling £625,000, the second loan note instrument (the "Second Loan") of up to £1m had subscriptions totalling £950,000, and the third loan note instrument (the "Third Loan") of up to £2m had subscriptions totalling £950,000, the Board is pleased to announce that a number of existing shareholders have collectively subscribed to a further £300,000 of the Third Loan.

 

This constitutes a related party transaction under Rule 13 of the AIM Rules as a result of OTK Holding A/S, which hold approximately 14% of the issued shares of the Company, subscribing to a further £135,000 of the Third Loan. The Third Loan is unsecured and carries annual interest of 10% which is to accrue and is repayable on the earlier of (i) 28 February 2025 or (ii) receipt of funds relating to either the US or UK Proceedings. Should repayment take place prior to 28 February 2025, a 20% early redemption premium shall apply.  The Directors of the Company, having consulted with WH Ireland Limited, the Company's nominated adviser, consider the terms of the transaction to be fair and reasonable in so far as shareholders are concerned.

 

The Third Loan will be used to provide ongoing working capital funding, including costs related to the US and UK Proceedings.

 

The Board believe that further subscriptions to the Third Loan may be necessary to ensure that the Company continues to protect its investment in Snorkel. Following discussions with the existing shareholders, if further subscriptions were required, the Board are of the opinion that further funding will be made available.

 

 

Legal Proceedings

 

The US Proceedings are continuing, with a jury trial currently expected to take place around the summer of 2023. The UK Proceedings are also continuing, with a trial scheduled for November 2022. The Board continue to believe that a positive outcome to either or both proceedings is possible. So far as it is necessary, the Company will continue to vigorously defend and advance its position in both proceedings, whilst continuing to seek advice. 

 

Further updates will be provided to Shareholders as and when appropriate.

 

 

 

For further information:

 

Tanfield Group Plc 020 7220 1666

Daryn Robinson

 

WH Ireland Limited - Nominated Advisor / Broker

James Joyce / Megan Liddell 020 7220 1666

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFFFSITFIVFIF
Date   Source Headline
30th Dec 20084:40 pmRNSSecond Price Monitoring Extn
30th Dec 20084:37 pmRNSPrice Monitoring Extension
29th Dec 20084:41 pmRNSSecond Price Monitoring Extn
29th Dec 20084:37 pmRNSPrice Monitoring Extension
24th Dec 200812:41 pmRNSSecond Price Monitoring Extn
24th Dec 200812:36 pmRNSPrice Monitoring Extension
22nd Dec 20084:35 pmRNSPrice Monitoring Extension
1st Dec 20084:40 pmRNSSecond Price Monitoring Extn
1st Dec 20084:35 pmRNSPrice Monitoring Extension
18th Nov 20084:43 pmRNSSecond Price Monitoring Extn
18th Nov 20084:38 pmRNSPrice Monitoring Extension
11th Nov 20087:00 amRNSChange of Adviser
31st Oct 20084:51 pmRNSSecond Price Monitoring Extn
31st Oct 20084:40 pmRNSPrice Monitoring Extension
16th Oct 20084:39 pmRNSPrice Monitoring Extension
10th Oct 20084:45 pmRNSSecond Price Monitoring Extn
10th Oct 20084:44 pmRNSPrice Monitoring Extension
7th Oct 20087:00 amRNSDirector/PDMR Shareholding
6th Oct 20089:19 amRNSDirector/PDMR Shareholding
6th Oct 20089:17 amRNSDirector/PDMR Shareholding
2nd Oct 20088:57 amRNSDirector/PDMR Shareholding
1st Oct 20085:12 pmRNSHolding(s) in Company
1st Oct 20087:00 amRNSDirector/PDMR Shareholding
30th Sep 20087:00 amRNSInterim Results
17th Sep 20084:42 pmRNSSecond Price Monitoring Extn
17th Sep 20084:37 pmRNSPrice Monitoring Extension
27th Aug 20089:50 amRNSHolding(s) in Company
7th Aug 200810:22 amRNSHolding(s) in Company
18th Jul 20089:28 amRNSHolding(s) in Company
17th Jul 20083:21 pmRNSFurther re Director/PDMR Shar
16th Jul 20084:57 pmRNSHolding(s) in Company
16th Jul 20084:41 pmRNSDirector/PDMR Shareholding
15th Jul 20087:00 amRNSEnova Systems Comments on Tan
14th Jul 20083:33 pmRNSHolding(s) in Company
14th Jul 20087:00 amRNSHolding(s) in Company
10th Jul 20084:41 pmRNSSecond Price Monitoring Extn
10th Jul 20084:35 pmRNSPrice Monitoring Extension
9th Jul 20085:05 pmRNSDirector/PDMR Shareholding
8th Jul 20084:33 pmRNSDirector/PDMR Shareholding
8th Jul 20084:14 pmRNSHolding(s) in Company
8th Jul 200811:08 amRNSHolding(s) in Company
4th Jul 20086:28 pmRNSNew Bank Facility
1st Jul 20084:41 pmRNSSecond Price Monitoring Extn
1st Jul 20084:35 pmRNSPrice Monitoring Extension
1st Jul 200812:28 pmRNSHolding(s) in Company
1st Jul 20087:00 amRNSTrading Statement
27th Jun 200810:43 amRNSShare Price Movement
19th May 200810:06 amRNSHolding(s) in Company
13th May 20086:44 amRNSDetail of Order Book
29th Apr 20084:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.